Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
Valuation Context
Market Cap
$527M
Small Cap
P/E (TTM)
15.2x
In-line
P/S (TTM)
6.2x
In-line
EV/EBITDA
8.0x
Discounted

A smaller-scale business, currently unprofitable, showing accelerating growth valued in line with the market.

Explore metrics